Loading…

The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs

The effects of lisofylline [(R)-1-(5-hydroxyhexyl)-3,7-dimethylxanthine] (LSF), an inhibitor of de novo phosphatidic acid (PA) generation, on sepsis-induced acute lung injury was studied using Hanford minipigs weighing 18 to 25 kg. Sepsis was induced by an intravenous infusion of Pseudomonas aerugin...

Full description

Saved in:
Bibliographic Details
Published in:American journal of respiratory and critical care medicine 1997-03, Vol.155 (3), p.928-936
Main Authors: HASEGAWA, N, OKA, Y, NAKAYAMA, M, BERRY, G. J, BURSTEN, S, RICE, G, RAFFIN, T. A
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c331t-69585ea40f576c2e6a951068b7dbe471cefa975bdac384c14730e770980756df3
cites
container_end_page 936
container_issue 3
container_start_page 928
container_title American journal of respiratory and critical care medicine
container_volume 155
creator HASEGAWA, N
OKA, Y
NAKAYAMA, M
BERRY, G. J
BURSTEN, S
RICE, G
RAFFIN, T. A
description The effects of lisofylline [(R)-1-(5-hydroxyhexyl)-3,7-dimethylxanthine] (LSF), an inhibitor of de novo phosphatidic acid (PA) generation, on sepsis-induced acute lung injury was studied using Hanford minipigs weighing 18 to 25 kg. Sepsis was induced by an intravenous infusion of Pseudomonas aeruginosa (1 x 10(6)/colony-forming units/kg/min over 2 h). Saline was used as the control vehicle. Six groups were studied: saline control group (SALINE: n = 5); sepsis control group (SEPSIS: n = 5); LSF control group (LSF: n = 5), which received a 25-mg/kgbolus of LSF 30 min before time zero followed by continuous infusion of 10 mg/kg/h throughout the study; LSF-treated septic groups, which were treated with LSF 30 min prior to sepsis (Pre: n = 5), 1 h postonset (Post-1 h: n = 8) or h postonset (Post-2 h: n = 8) of the bacterial infusion. Hemodynamics PaO2, neutrophil counts, and plasma porcine tumor necrosis factor-alpha concentrations were monitored for 6 h. After the minipigs were killed, lung tissue was sampled to measured wet-to-dry weight ratio (W/D), tissue albumin index (TAI), thiobarbituric acid-reactive material content (TBARM), and myeloperoxidase (MPO) activity. Compared with the SALINE group, the SEPSIS group showed significant systemic hypotension, pulmonary hypertension, arterial hypoxemia, neutropenia, and increase in TNF-alpha, MPO activity, W/D, TBARM, and TAI. LSF treatment attenuated sepsis-induced pulmonary hypertension, neutropenia, and hypoxemia, and increased MPO activity and lung injury measurements in the Pre and Post-1 h groups, but its efficacy was blunted in the Post-2 h group. Plasma TNF-alpha was decreased only in the Pre group. Thus, inhibition of intracellular PA generation through de novo pathways attenuates sepsis-induced acute lung injury.
doi_str_mv 10.1164/ajrccm.155.3.9117028
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78953733</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78953733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c331t-69585ea40f576c2e6a951068b7dbe471cefa975bdac384c14730e770980756df3</originalsourceid><addsrcrecordid>eNpFkM1u1DAUhS0EKqXwBiB5gVg1gx3bcbJEFX9SJTZFYmc5zvXEo8QJvo6qeQDeG6OJyur-nO-cxSHkLWcHzhv50Z6Sc_OBK3UQh45zzer2GbnmSqhKdpo9LzvTopKy-_WSvEI8McbrlrMrcrXj1-TPwwgUvAeXkS6ergvmKieweYaY6WPII50CLv48TSHCLbV0HRdcR5vDEBy1Lgz0CBFSeSyRhjiGPuQl3dJyIawYsApx2BwMBd4y0GmLx8KdtnQug67hiK_JC28nhDf7vCE_v3x-uPtW3f_4-v3u033lhOC5ajrVKrCSeaUbV0NjO8VZ0_Z66EFq7sDbTqt-sE600nGpBQOtWdcyrZrBixvy4ZK7puX3BpjNHNDBNNkIy4ZGt50SWogCygvo0oKYwJs1hdmms-HM_GvfXNo3pX0jzF5nsb3b87d-huHJ9F9_v-sWnZ18stEFfMLqptZaS_EXdaSRFg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78953733</pqid></control><display><type>article</type><title>The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs</title><source>Freely Accessible Science Journals</source><source>Free E-Journal (出版社公開部分のみ)</source><creator>HASEGAWA, N ; OKA, Y ; NAKAYAMA, M ; BERRY, G. J ; BURSTEN, S ; RICE, G ; RAFFIN, T. A</creator><creatorcontrib>HASEGAWA, N ; OKA, Y ; NAKAYAMA, M ; BERRY, G. J ; BURSTEN, S ; RICE, G ; RAFFIN, T. A</creatorcontrib><description>The effects of lisofylline [(R)-1-(5-hydroxyhexyl)-3,7-dimethylxanthine] (LSF), an inhibitor of de novo phosphatidic acid (PA) generation, on sepsis-induced acute lung injury was studied using Hanford minipigs weighing 18 to 25 kg. Sepsis was induced by an intravenous infusion of Pseudomonas aeruginosa (1 x 10(6)/colony-forming units/kg/min over 2 h). Saline was used as the control vehicle. Six groups were studied: saline control group (SALINE: n = 5); sepsis control group (SEPSIS: n = 5); LSF control group (LSF: n = 5), which received a 25-mg/kgbolus of LSF 30 min before time zero followed by continuous infusion of 10 mg/kg/h throughout the study; LSF-treated septic groups, which were treated with LSF 30 min prior to sepsis (Pre: n = 5), 1 h postonset (Post-1 h: n = 8) or h postonset (Post-2 h: n = 8) of the bacterial infusion. Hemodynamics PaO2, neutrophil counts, and plasma porcine tumor necrosis factor-alpha concentrations were monitored for 6 h. After the minipigs were killed, lung tissue was sampled to measured wet-to-dry weight ratio (W/D), tissue albumin index (TAI), thiobarbituric acid-reactive material content (TBARM), and myeloperoxidase (MPO) activity. Compared with the SALINE group, the SEPSIS group showed significant systemic hypotension, pulmonary hypertension, arterial hypoxemia, neutropenia, and increase in TNF-alpha, MPO activity, W/D, TBARM, and TAI. LSF treatment attenuated sepsis-induced pulmonary hypertension, neutropenia, and hypoxemia, and increased MPO activity and lung injury measurements in the Pre and Post-1 h groups, but its efficacy was blunted in the Post-2 h group. Plasma TNF-alpha was decreased only in the Pre group. Thus, inhibition of intracellular PA generation through de novo pathways attenuates sepsis-induced acute lung injury.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/ajrccm.155.3.9117028</identifier><identifier>PMID: 9117028</identifier><language>eng</language><publisher>New York, NY: American Lung Association</publisher><subject><![CDATA[Adjuvants, Immunologic - administration & dosage ; Adjuvants, Immunologic - therapeutic use ; Animals ; Biological and medical sciences ; Disease Models, Animal ; Female ; Hemodynamics ; Lung - pathology ; Male ; Medical sciences ; Miscellaneous ; Pentoxifylline - administration & dosage ; Pentoxifylline - analogs & derivatives ; Pentoxifylline - therapeutic use ; Pharmacology. Drug treatments ; Phosphatidic Acids - antagonists & inhibitors ; Pseudomonas Infections ; Respiratory Distress Syndrome, Adult - etiology ; Respiratory Distress Syndrome, Adult - prevention & control ; Shock, Septic - microbiology ; Shock, Septic - physiopathology ; Shock, Septic - prevention & control ; Swine ; Swine, Miniature ; Time Factors]]></subject><ispartof>American journal of respiratory and critical care medicine, 1997-03, Vol.155 (3), p.928-936</ispartof><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c331t-69585ea40f576c2e6a951068b7dbe471cefa975bdac384c14730e770980756df3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2627774$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9117028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>HASEGAWA, N</creatorcontrib><creatorcontrib>OKA, Y</creatorcontrib><creatorcontrib>NAKAYAMA, M</creatorcontrib><creatorcontrib>BERRY, G. J</creatorcontrib><creatorcontrib>BURSTEN, S</creatorcontrib><creatorcontrib>RICE, G</creatorcontrib><creatorcontrib>RAFFIN, T. A</creatorcontrib><title>The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>The effects of lisofylline [(R)-1-(5-hydroxyhexyl)-3,7-dimethylxanthine] (LSF), an inhibitor of de novo phosphatidic acid (PA) generation, on sepsis-induced acute lung injury was studied using Hanford minipigs weighing 18 to 25 kg. Sepsis was induced by an intravenous infusion of Pseudomonas aeruginosa (1 x 10(6)/colony-forming units/kg/min over 2 h). Saline was used as the control vehicle. Six groups were studied: saline control group (SALINE: n = 5); sepsis control group (SEPSIS: n = 5); LSF control group (LSF: n = 5), which received a 25-mg/kgbolus of LSF 30 min before time zero followed by continuous infusion of 10 mg/kg/h throughout the study; LSF-treated septic groups, which were treated with LSF 30 min prior to sepsis (Pre: n = 5), 1 h postonset (Post-1 h: n = 8) or h postonset (Post-2 h: n = 8) of the bacterial infusion. Hemodynamics PaO2, neutrophil counts, and plasma porcine tumor necrosis factor-alpha concentrations were monitored for 6 h. After the minipigs were killed, lung tissue was sampled to measured wet-to-dry weight ratio (W/D), tissue albumin index (TAI), thiobarbituric acid-reactive material content (TBARM), and myeloperoxidase (MPO) activity. Compared with the SALINE group, the SEPSIS group showed significant systemic hypotension, pulmonary hypertension, arterial hypoxemia, neutropenia, and increase in TNF-alpha, MPO activity, W/D, TBARM, and TAI. LSF treatment attenuated sepsis-induced pulmonary hypertension, neutropenia, and hypoxemia, and increased MPO activity and lung injury measurements in the Pre and Post-1 h groups, but its efficacy was blunted in the Post-2 h group. Plasma TNF-alpha was decreased only in the Pre group. Thus, inhibition of intracellular PA generation through de novo pathways attenuates sepsis-induced acute lung injury.</description><subject>Adjuvants, Immunologic - administration &amp; dosage</subject><subject>Adjuvants, Immunologic - therapeutic use</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Hemodynamics</subject><subject>Lung - pathology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pentoxifylline - administration &amp; dosage</subject><subject>Pentoxifylline - analogs &amp; derivatives</subject><subject>Pentoxifylline - therapeutic use</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphatidic Acids - antagonists &amp; inhibitors</subject><subject>Pseudomonas Infections</subject><subject>Respiratory Distress Syndrome, Adult - etiology</subject><subject>Respiratory Distress Syndrome, Adult - prevention &amp; control</subject><subject>Shock, Septic - microbiology</subject><subject>Shock, Septic - physiopathology</subject><subject>Shock, Septic - prevention &amp; control</subject><subject>Swine</subject><subject>Swine, Miniature</subject><subject>Time Factors</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNpFkM1u1DAUhS0EKqXwBiB5gVg1gx3bcbJEFX9SJTZFYmc5zvXEo8QJvo6qeQDeG6OJyur-nO-cxSHkLWcHzhv50Z6Sc_OBK3UQh45zzer2GbnmSqhKdpo9LzvTopKy-_WSvEI8McbrlrMrcrXj1-TPwwgUvAeXkS6ergvmKieweYaY6WPII50CLv48TSHCLbV0HRdcR5vDEBy1Lgz0CBFSeSyRhjiGPuQl3dJyIawYsApx2BwMBd4y0GmLx8KdtnQug67hiK_JC28nhDf7vCE_v3x-uPtW3f_4-v3u033lhOC5ajrVKrCSeaUbV0NjO8VZ0_Z66EFq7sDbTqt-sE600nGpBQOtWdcyrZrBixvy4ZK7puX3BpjNHNDBNNkIy4ZGt50SWogCygvo0oKYwJs1hdmms-HM_GvfXNo3pX0jzF5nsb3b87d-huHJ9F9_v-sWnZ18stEFfMLqptZaS_EXdaSRFg</recordid><startdate>19970301</startdate><enddate>19970301</enddate><creator>HASEGAWA, N</creator><creator>OKA, Y</creator><creator>NAKAYAMA, M</creator><creator>BERRY, G. J</creator><creator>BURSTEN, S</creator><creator>RICE, G</creator><creator>RAFFIN, T. A</creator><general>American Lung Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970301</creationdate><title>The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs</title><author>HASEGAWA, N ; OKA, Y ; NAKAYAMA, M ; BERRY, G. J ; BURSTEN, S ; RICE, G ; RAFFIN, T. A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c331t-69585ea40f576c2e6a951068b7dbe471cefa975bdac384c14730e770980756df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adjuvants, Immunologic - administration &amp; dosage</topic><topic>Adjuvants, Immunologic - therapeutic use</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Hemodynamics</topic><topic>Lung - pathology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pentoxifylline - administration &amp; dosage</topic><topic>Pentoxifylline - analogs &amp; derivatives</topic><topic>Pentoxifylline - therapeutic use</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphatidic Acids - antagonists &amp; inhibitors</topic><topic>Pseudomonas Infections</topic><topic>Respiratory Distress Syndrome, Adult - etiology</topic><topic>Respiratory Distress Syndrome, Adult - prevention &amp; control</topic><topic>Shock, Septic - microbiology</topic><topic>Shock, Septic - physiopathology</topic><topic>Shock, Septic - prevention &amp; control</topic><topic>Swine</topic><topic>Swine, Miniature</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HASEGAWA, N</creatorcontrib><creatorcontrib>OKA, Y</creatorcontrib><creatorcontrib>NAKAYAMA, M</creatorcontrib><creatorcontrib>BERRY, G. J</creatorcontrib><creatorcontrib>BURSTEN, S</creatorcontrib><creatorcontrib>RICE, G</creatorcontrib><creatorcontrib>RAFFIN, T. A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HASEGAWA, N</au><au>OKA, Y</au><au>NAKAYAMA, M</au><au>BERRY, G. J</au><au>BURSTEN, S</au><au>RICE, G</au><au>RAFFIN, T. A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>1997-03-01</date><risdate>1997</risdate><volume>155</volume><issue>3</issue><spage>928</spage><epage>936</epage><pages>928-936</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>The effects of lisofylline [(R)-1-(5-hydroxyhexyl)-3,7-dimethylxanthine] (LSF), an inhibitor of de novo phosphatidic acid (PA) generation, on sepsis-induced acute lung injury was studied using Hanford minipigs weighing 18 to 25 kg. Sepsis was induced by an intravenous infusion of Pseudomonas aeruginosa (1 x 10(6)/colony-forming units/kg/min over 2 h). Saline was used as the control vehicle. Six groups were studied: saline control group (SALINE: n = 5); sepsis control group (SEPSIS: n = 5); LSF control group (LSF: n = 5), which received a 25-mg/kgbolus of LSF 30 min before time zero followed by continuous infusion of 10 mg/kg/h throughout the study; LSF-treated septic groups, which were treated with LSF 30 min prior to sepsis (Pre: n = 5), 1 h postonset (Post-1 h: n = 8) or h postonset (Post-2 h: n = 8) of the bacterial infusion. Hemodynamics PaO2, neutrophil counts, and plasma porcine tumor necrosis factor-alpha concentrations were monitored for 6 h. After the minipigs were killed, lung tissue was sampled to measured wet-to-dry weight ratio (W/D), tissue albumin index (TAI), thiobarbituric acid-reactive material content (TBARM), and myeloperoxidase (MPO) activity. Compared with the SALINE group, the SEPSIS group showed significant systemic hypotension, pulmonary hypertension, arterial hypoxemia, neutropenia, and increase in TNF-alpha, MPO activity, W/D, TBARM, and TAI. LSF treatment attenuated sepsis-induced pulmonary hypertension, neutropenia, and hypoxemia, and increased MPO activity and lung injury measurements in the Pre and Post-1 h groups, but its efficacy was blunted in the Post-2 h group. Plasma TNF-alpha was decreased only in the Pre group. Thus, inhibition of intracellular PA generation through de novo pathways attenuates sepsis-induced acute lung injury.</abstract><cop>New York, NY</cop><pub>American Lung Association</pub><pmid>9117028</pmid><doi>10.1164/ajrccm.155.3.9117028</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1073-449X
ispartof American journal of respiratory and critical care medicine, 1997-03, Vol.155 (3), p.928-936
issn 1073-449X
1535-4970
language eng
recordid cdi_proquest_miscellaneous_78953733
source Freely Accessible Science Journals; Free E-Journal (出版社公開部分のみ)
subjects Adjuvants, Immunologic - administration & dosage
Adjuvants, Immunologic - therapeutic use
Animals
Biological and medical sciences
Disease Models, Animal
Female
Hemodynamics
Lung - pathology
Male
Medical sciences
Miscellaneous
Pentoxifylline - administration & dosage
Pentoxifylline - analogs & derivatives
Pentoxifylline - therapeutic use
Pharmacology. Drug treatments
Phosphatidic Acids - antagonists & inhibitors
Pseudomonas Infections
Respiratory Distress Syndrome, Adult - etiology
Respiratory Distress Syndrome, Adult - prevention & control
Shock, Septic - microbiology
Shock, Septic - physiopathology
Shock, Septic - prevention & control
Swine
Swine, Miniature
Time Factors
title The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A00%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20post-treatment%20with%20lisofylline,%20a%20phosphatidic%20acid%20generation%20inhibitor,%20on%20sepsis-induced%20acute%20lung%20injury%20in%20pigs&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=HASEGAWA,%20N&rft.date=1997-03-01&rft.volume=155&rft.issue=3&rft.spage=928&rft.epage=936&rft.pages=928-936&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/ajrccm.155.3.9117028&rft_dat=%3Cproquest_cross%3E78953733%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c331t-69585ea40f576c2e6a951068b7dbe471cefa975bdac384c14730e770980756df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78953733&rft_id=info:pmid/9117028&rfr_iscdi=true